Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

CMS Says U.S. Health Spending to Rise 5.5% Per Year over Next Decade

Tamara Mathias and Saumya Joseph  |  February 20, 2019

(Reuters)—U.S. health spending is expected to grow at an average rate of 5.5% every year from 2018 over the next decade and will reach nearly $6 trillion by 2027 as more people become eligible for Medicare, a government health agency said on Wednesday.

Rising income levels, better employment rate and more people enrolling for Medicare, the federal health insurance program for people aged 65 and above and the disabled, will cause healthcare spending to rise to 19.4% of the U.S. economy by 2027, the Centers for Medicare & Medicaid Services (CMS) said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In 2017, healthcare spending accounted for 17.9% of the country’s gross domestic product.

Annual spending growth for Medicare is expected to average 7.4% over the 10-year period, CMS said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

That number exceeds spending projections for Medicaid—the government insurance program for low income Americans—and private health insurance plans, which are expected to average 5.5% and 4.8% respectively, over the same period.

The CMS said it expects Medicare enrollment growth to peak at 2.9% in 2019.

Prescription drug spending is also expected to rise and average 5.6% annually between 2018 and 2027 as employers and insurers push patients with chronic conditions to adhere to medications better, and as new and expensive drugs enter the market.

Hospital spending growth is projected to average 5.6% per year between 2018 and 2027.

By 2027, federal, state and local governments are expected to fund 47% of national health spending, compared with 45 percent in 2017, according to the report.

The CMS said that all projections are reflective of current laws and do not take into account policy changes under consideration.

 

Share: 

Filed under:Practice Support Tagged with:healthcare spendinghealthcare spending increasespending growth rate

Related Articles

    The RISE Registry: A Powerful Collaboration Tool for Clinicians & Researchers

    March 21, 2019

    Practice-based evidence, like that in the RISE registry, can be used to describe trends in patient care, look at comparative effectiveness of interventions and much more.

    The RISE Registry Delivers Practice-Based Evidence to Rheumatologists

    April 15, 2019

    The advent of quality-based healthcare, such as the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), requires rheumatology professionals to demonstrate their practice is based on interventions supported by the best available evidence and that their practice, in turn, provides quality care. These requirements have increased the need for methods to measure and quantify…

    Using RISE Data in Research

    October 17, 2019

    The ACR’s RISE registry offers answers on real-world experience to researchers.

    Rheumatology Informatics System for Effectiveness (RISE) Registry Can Help Rheumatologists Meet MACRA Requirements

    August 10, 2016

    The ACR has been at the forefront of helping rheumatologists meet practice demands, including federal reporting requirements. The first registry that helped meet these requirements was the Rheumatology Clinical Registry (RCR), and it facilitated quality reporting, but required manual entry of required data. More recently, ACR has contracted with FIGmd to create a tool that…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences